Good Acceptance Records Are Key When FDA Comes Calling

Devicemakers may need to brush up on their acceptance activities, as these are among the most frequently cited issues in warning letters for 2012 and 2013, says Dan O’Leary, partner with Ombu Enterprises.
The GMP Letter